A prognostic genomic test for breast cancer that assesses individual cancer risk and treatment response. This molecular diagnostic helps guide clinical decision-making for breast cancer patients.
Manufactured by
United States
The Eurobio Scientific Group leads breakthrough innovation in the fields of infectious diseases, transplantation, and oncology by developing and supporting a comprehensive portfolio of molecular diagnostics and immunoassay technologies. The EurobioPlex products are nucleic acid-based diagnostic tests for the detection of various infectious diseases, fertility, and dermatological conditions. The GenBio products are in vitro diagnostic test kits intended to identify the presence of antibodies to specific infectious and autoimmune diseases.
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
ONCOMEDICS SAS
France · 2 relevant products
Wuhan YZY Medical Science and Technology Co.,Ltd.
China · 5 relevant products
Shenzhen HaploX Biotechnology Co., Ltd.
China · 3 relevant products
HOLOGIC
China · 2 relevant products
YouSeq
United Kingdom · 2 relevant products
Shanghai Biotecan pharmaceuticals Co.,Ltd
China · 4 relevant products
Singlera GENOMICS (SHANGHAI) Ltd.
China · 7 relevant products
Yaneng BIOscience (Shenzhen) Co.,Ltd.
China · 2 relevant products
Bio Preventive Medicine Co. Ltd.
Taiwan · 2 relevant products
Helio Diagnostics
France · 1 relevant product
51 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →15 more sourcing countries available
Get free access to all sourcing countries identified for this product.
See all countries →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
12 of 98 closest product alternatives
ONCOMEDICS SAS · France
A predictive test for personalization of anti-tumor treatment. This diagnostic tool is designed to assist in tailoring cancer treatment strategies to individual patient needs.
Wuhan YZY Medical Science and Technology Co.,Ltd. · China
In vitro diagnostic test for identifying genetic biomarkers that predict treatment response in cancer patients. Guides selection of targeted therapies and treatment protocols.
ONCOMEDICS SAS · France
Oncogramme® is a diagnostic test that analyzes tumor chemosensitivity and drug response patterns to guide personalized cancer treatment selection. The test evaluates cancer cell sensitivity to multiple therapeutic agents, enabling oncologists to optimize treatment protocols based on individual tumor biology and improve clinical outcomes.
Shenzhen HaploX Biotechnology Co., Ltd. · China
A targeted diagnostic test analyzing 21 genes relevant to breast cancer. This test assesses genomic markers for prognosis and treatment planning in breast cancer patients.
HOLOGIC · China
Advanced molecular testing for genetic markers to inform personalized treatment decisions in breast cancer and other women's health conditions.
YouSeq · United Kingdom
A multiplex molecular panel utilizing qPCR and NGS technology for detection of breast cancer-associated genetic markers and mutations. Supports diagnostic confirmation and prognostic assessment for breast cancer management.
Shanghai Biotecan pharmaceuticals Co.,Ltd · China
Precision medicine test identifying optimal chemotherapy agents for individual tumors based on molecular characteristics. Guides targeted drug selection and improves treatment efficacy.
Singlera GENOMICS (SHANGHAI) Ltd. · China
A DNA methylation-based molecular diagnostic test designed for early detection and risk assessment across multiple cancer types. The test utilizes proprietary methylation technology to identify cancer signals in biological samples.
Yaneng BIOscience (Shenzhen) Co.,Ltd. · China
Molecular testing kit for detecting breast cancer-related genetic alterations, enabling risk stratification and clinical decision-making in oncology care.
Bio Preventive Medicine Co. Ltd. · Taiwan
A predictive diagnostic test that evaluates the risk of progression to end-stage kidney disease in patients with diabetic kidney disease. The test identifies patients at high risk during the critical intervention window to prevent dialysis dependency.
Helio Diagnostics · France
Oncology-focused diagnostic assays including tumor markers and genetic testing solutions. Developed with clinical evidence, validated processes, and regulatory pathways established for market approval.
APPOLON BIOTECK SAS · France
In vitro diagnostic devices for oncology applications focusing on genetic mutation detection and biomarker analysis. Supports clinical decision-making through comprehensive molecular profiling.
86 more product alternatives available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products